Volume 11, Issue 4 (12-2023)
Jorjani Biomed J 2023, 11(4): 8-10 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Heidarzadeh S, Ashrafmansouri S. Molecular docking study of cytochalasin H and Fascin interactions as prospective targets for gastric cancer. Jorjani Biomed J 2023; 11 (4) :8-10
URL: http://goums.ac.ir/jorjanijournal/article-1-1002-en.html
URL: http://goums.ac.ir/jorjanijournal/article-1-1002-en.html
1- Department of Biology, Faculty of Science, University of Zabol, Zabol, Iran
2- Department of Biology, School of Science, Shiraz University, Shiraz, Iran ,s.ashrafmansouri@shirazu.ac.ir
2- Department of Biology, School of Science, Shiraz University, Shiraz, Iran ,
Abstract: (1039 Views)
Background: Gastric cancer is the fifth most common neoplasm and the fourth leading cause of mortality worldwide. Incidence rates vary widely and depend on risk factors, epidemiological factors, and carcinogenesis patterns. Understanding the molecular mechanisms underlying cancer progression and metastasis is crucial for developing effective therapeutic strategies. Previous studies have reported that fascin overexpression, an actin-binding protein, promotes cell motility and invasion in cancers by bundling actin filaments. Therefore, inhibiting this protein can be a major step in treatment.
Methods: In this prospective study, the protein structure of fascin was obtained from the Protein Data Bank (PDB). Using the HyperChem 7.0 software, the chemical structure of cytochalasin H as a small molecule inhibitor was designed. Rigid docking studies between cytochalasin H and fascin protein were performed using the AutoDock Vina 1.1.2 software, and the obtained results were analyzed using LigPlot+ v.1.4.5, Discovery Studio 4.5, and PyMOL v.1.9 software.
Results: According to the analyses and the obtained results, cytochalasin H and fascin protein have an effective interaction with an optimal energy level.
Conclusion: These findings suggest that cytochalasin H may be developed into a potential chemotherapeutic drug for the treatment of gastric cancer by inhibiting fascin. Nevertheless, further in vitro and in vivo experiments are necessary to elucidate the exact mechanism.
Methods: In this prospective study, the protein structure of fascin was obtained from the Protein Data Bank (PDB). Using the HyperChem 7.0 software, the chemical structure of cytochalasin H as a small molecule inhibitor was designed. Rigid docking studies between cytochalasin H and fascin protein were performed using the AutoDock Vina 1.1.2 software, and the obtained results were analyzed using LigPlot+ v.1.4.5, Discovery Studio 4.5, and PyMOL v.1.9 software.
Results: According to the analyses and the obtained results, cytochalasin H and fascin protein have an effective interaction with an optimal energy level.
Conclusion: These findings suggest that cytochalasin H may be developed into a potential chemotherapeutic drug for the treatment of gastric cancer by inhibiting fascin. Nevertheless, further in vitro and in vivo experiments are necessary to elucidate the exact mechanism.
Keywords: Cytochalasin H, Drug design, Fascin protein, Molecular docking simulation, Stomach neoplasms
Type of Article: Original article |
Subject:
Molecular Sciences
Received: 2023/07/30 | Accepted: 2023/12/24 | Published: 2023/12/30
Received: 2023/07/30 | Accepted: 2023/12/24 | Published: 2023/12/30
References
1. Bray F, Ferlay J, Soerjomataram I, Siegel R, Torre L, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424. [View at Publisher] [DOI] [PMID] [Google Scholar]
2. Rawla P, Barsouk A. Epidemiology of gastric cancer: global trends, risk factors and prevention. 2019;14(1):26-38. [View at Publisher] [DOI] [PMID] [Google Scholar]
3. Fritz A, Editor. International Classification of Diseases for Oncology (ICD-O). 3rd ed. 1st Rev. WHO;2000:240 p. [View at Publisher] [Google Scholar]
4. Kelley JR, Duggan JM. Gastric cancer epidemiology and risk factors. J Clin Epidemiol. 2003;56(1):1-9. [View at Publisher] [DOI] [PMID] [Google Scholar]
5. Gupta GP, Massague J. Cancer metastasis: building a framework. Cell. 2006;127(4):679-95. [View at Publisher] [DOI] [PMID] [Google Scholar]
6. Buday L, Downward J. Roles of cortactin in tumor pathogenesis. Biochim Biophys Acta. 2007;1775(2): 263-73. [View at Publisher] [DOI] [PMID] [Google Scholar]
7. Hashimoto Y, Ito T, Inoue H, Okumura T, Tanaka E, Tsunoda Sh, et al. Prognostic significance of fascin overexpression in human esophageal squamous cell carcinoma. Clin Cancer Res. 2005;11(7):2597-605. [View at Publisher] [DOI] [PMID] [Google Scholar]
8. Smith SC, Theodorescu D. Learning therapeutic lessons from metastasis suppressor proteins. Nat Rev Cancer. 2009;9(4):253-64. [View at Publisher] [DOI] [PMID] [Google Scholar]
9. Valastyan S, Weinberg RA. Tumor metastasis: molecular insights and evolving paradigms. Cell. 2011;147(2):275-92. [View at Publisher] [DOI] [PMID] [Google Scholar]
10. Chen L, Yang Sh, Jakoncic J, Zhang J, Huang X. Migrastatin analogues target fascin to block tumour metastasis. Nature. 2010;464(7291):1062-66. [View at Publisher] [DOI] [PMID] [Google Scholar]
11. Hashimoto Y, Kim DJ, Adams JC. The roles of fascins in health and disease. J Pathol. 2011;224(3):289-300. [View at Publisher] [DOI] [PMID] [Google Scholar]
12. Hashimoto Y, Shimada Y, Kawamura J, Yamasaki S, Imamura M. The prognostic relevance of fascin expression in human gastric carcinoma. Oncology. 2004;67(3-4):262-70. [View at Publisher] [DOI] [PMID] [Google Scholar]
13. Van Goietsenoven G, Mathieu V, Andolfi A, Cimmino A, Lefranc F, Kiss R, et al. In vitro growth inhibitory effects of cytochalasins and derivatives in cancer cells. Planta Med. 2011;77(7):711- 17. [View at Publisher] [DOI] [PMID] [Google Scholar]
14. Cooper JA. Effects of cytochalasin and phalloidin on actin. J Cell Biol. 1987;105(4):1473-8. [View at Publisher] [DOI] [PMID] [Google Scholar]
15. Haidle AM, Myers AG. An enantioselective, modular, and general route to the cytochalasins: synthesis of L-696,474 and cytochalasin B. Proc Natl Acad Sci U S A. 2004;101(33):12048-53. [View at Publisher] [DOI] [PMID] [Google Scholar]
16. Deshmukh PG, Kanitkar UK, Pendse GS. A new fungal isolate from Paspalum scrobiculatum, Linn, with new biologically active metabolites. Acta Microbiol Acad Sci Hung. 1975;22(3):253-62. [View at Publisher] [Google Scholar]
17. Chapla VM, Zeraik ML, Ximenes V, Zanardi LM, Lopes M, Cavalheiro A, et al. Bioactive secondary metabolites from Phomopsis sp., an endophytic fungus from Senna spectabilis. Molecules. 2014;19(5):6597-608. [View at Publisher] [DOI] [PMID] [Google Scholar]
18. Yi JM, Kim J, Park JS, Lee J, Lee YJ, Hong JT, et al. In vivo anti-tumor effects of the ethanol extract of gleditsia sinensis thorns and its active constituent, cytochalasin h. Biol Pharm Bull. 2015;38(6):909-12. [View at Publisher] [DOI] [PMID] [Google Scholar]
19. Jayo A, Parsons M. Fascin: A key regulator of cytoskeletal dynamics. Int J Biochem. Cell Biol. 2010;42(10):1614-7. [View at Publisher] [DOI] [PMID] [Google Scholar]
20. Mohd AR, Swaleha Z, Asim A. Ligand docking and binding site analysis with pymol and autodock/vina. International Journal of Basic and Applied Sciences. 2015;4(2):168-77. [View at Publisher] [DOI] [Google Scholar]
21. Phillips MA, Stewart MA, Woodling DL, Xie ZR. Has Molecular Docking Ever Brought us a Medicine? BoD – Books on Demand;2018. [View at Publisher] [DOI] [Google Scholar]
22. Zolfaghari N. Molecular docking analysis of nitisinone with homogentisate 1,2 dioxygenase. Bioinformation. 2017;13(5):136-9. [View at Publisher] [DOI] [PMID] [Google Scholar]
23. Xiong SL, Yue LM, Lim GT, Yang JM, Lee J, Park YD, et al. Inhibitory effect of raspberry ketone on α-glucosidase: Docking simulation integrating inhibition kinetics. Int J Biol Macromol. 2018;113:212-8. [View at Publisher] [DOI] [PMID] [Google Scholar]
24. Imani-Saber Z, Ghafouri-Fard S. In Silico Interaction and Docking Studies Indicate a New Mechanism for PML Dysfunction in Gastric Cancer and Suggest Imatinib as a Drug to Restore Function. Asian Pac J Cancer Prev. 2015;16(12):5005-6. [View at Publisher] [DOI] [PMID] [Google Scholar]
25. Zhang FR, Tao LH, Shen ZY, Lv Z, Xu LY, Li EM. Fascin expression in human embryonic, fetal, and normal adult tissue. J Histochem Cytochem. 2008;56(2):193-9. [View at Publisher] [DOI] [PMID] [Google Scholar]
26. Feitosa A, Ferreira F, Brigido H, Bastos M, Carvalho J, Carneiro A, et al. Study on Experimental Leishmanicidal Activity and in silico of Cytochalasin B. J Braz Chem Soc. 2019;30(3):592-6. [View at Publisher] [Google Scholar]
27. Ma Y, Wu X, Xiu Z, Liu X, Huang B, Hu L, et al. Cytochalasin H isolated from mangrove derived endophytic fungus induces apoptosis and inhibits migration in lung cancer cells. Oncol Rep. 2018;39(6):2899-905. [View at Publisher] [DOI] [Google Scholar]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
